Scarica l'app Stockscreener
3.6608
2.65%
-0.1092
Precedente Chiudi:
$3.77
Aprire:
$3.8
Volume 24 ore:
2.98M
Relative Volume:
0.51
Capitalizzazione di mercato:
$1.25B
Reddito:
-
Utile/perdita netta:
$-75.80M
Rapporto P/E:
-10.46
EPS:
-0.35
Flusso di cassa netto:
$-68.07M
1 W Prestazione:
-2.13%
1M Prestazione:
+12.23%
6M Prestazione:
+95.21%
1 anno Prestazione:
+42.80%
Intervallo 1D:
$3.66
$3.835
Intervallo di 1 settimana:
$3.50
$3.835
Portata 52W:
$1.54
$4.0899
Nuvation Bio Inc Stock (NUVB) Company Profile
Nome
Nuvation Bio Inc
Settore
Industria
Telefono
(415) 754-3517
Indirizzo
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
Confronta NUVB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
3.665 | 1.22B | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.29 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
485.38 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.41 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
831.04 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
317.82 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-30 | Iniziato | Jefferies | Buy |
| 2025-04-23 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-03-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-03-26 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-02 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-03-08 | Iniziato | BMO Capital Markets | Outperform |
| 2021-03-08 | Iniziato | BTIG Research | Buy |
| 2021-03-08 | Iniziato | Cowen | Outperform |
| 2021-03-08 | Iniziato | Jefferies | Buy |
| 2021-03-08 | Iniziato | Wedbush | Outperform |
Mostra tutto
Nuvation Bio Inc Borsa (NUVB) Ultime notizie
Will Nuvation Bio Inc. price bounce be sustainable2025 AllTime Highs & Daily Chart Pattern Signals - newser.com
Applying Wyckoff theory to Nuvation Bio Inc. stock2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Is Nuvation Bio Inc. stock resilient to inflationQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Chart based exit strategy for Nuvation Bio Inc.July 2025 Earnings & Daily Stock Trend Reports - newser.com
Is Nuvation Bio Inc. stock ready for a breakout2025 Market Trends & Weekly Market Pulse Updates - newser.com
Nuvation Bio rings NYSE closing bell marking commercial milestone - Traders Union
Real time pattern detection on Nuvation Bio Inc. stock2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
IBTROZI Approvals, Phase 3 Trials, And Strong Cash Position Make NUVB A Biotech To Watch - RTTNews
Intraday pattern recognizer results for Nuvation Bio Inc.July 2025 Earnings & Long Hold Capital Preservation Tips - newser.com
Why Nuvation Bio Inc. stock is popular among millennialsQuarterly Market Summary & Reliable Breakout Forecasts - newser.com
Has Nuvation Bio Inc. formed a bullish divergenceWeekly Trade Summary & Growth Oriented Trading Recommendations - newser.com
Does Nuvation Bio’s (NUVB) Global Phase 3 Taletrectinib Trial Shift Its Oncology Ambitions? - Sahm
Real time social sentiment graph for Nuvation Bio Inc.2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - newser.com
Will Nuvation Bio Inc. stock continue dividend increasesPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Can a trend reversal in Nuvation Bio Inc. lead to recoveryWeekly Market Report & Fast Moving Stock Watchlists - newser.com
Will Nuvation Bio Inc. Class stock top growth indexesProfit Target & Safe Capital Growth Plans - newser.com
How hedge fund analytics apply to Nuvation Bio Inc. stockWeekly Risk Summary & Weekly Setup with High ROI Potential - newser.com
Is Nuvation Bio Inc. reversing from oversold territoryJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Smart tools for monitoring Nuvation Bio Inc.’s price actionWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
How big funds are accumulating Nuvation Bio Inc. Warrants stockWeekly Market Report & Precise Entry and Exit Recommendations - newser.com
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street - Investing News Network
What market sentiment indicators show for Nuvation Bio Inc. Class stockPortfolio Gains Summary & Accurate Trade Setup Notifications - newser.com
Nuvation Bio Inc. (NUVB): A Bull Case Theory - MSN
Nuvation Bio Inc Stock Analysis and ForecastStop Loss Placement Tips & Big Gains Small Investment - earlytimes.in
Nuvation Bio (NUVB): Valuation in Focus as Phase 3 Lung Cancer Trial Launches - Sahm
Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch - simplywall.st
NYSE Composite Tracks Nuvation Bio’s Operational Benchmarks - Kalkine Media
How moving averages guide Nuvation Bio Inc. trading2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
How Nuvation Bio Inc. Class stock moves in volatile trading sessionsMarket Growth Summary & Stepwise Trade Execution Plans - newser.com
Is Nuvation Bio Inc. Warrants stock undervalued after correctionRisk Management & Weekly High Conviction Ideas - newser.com
Will Nuvation Bio Inc. Warrants stock sustain uptrend momentum - newser.com
Can Nuvation Bio Inc. Class stock resist broad market declinesJuly 2025 Setups & Weekly High Return Forecasts - newser.com
Is Nuvation Bio Inc. Warrants stock inflation resilientJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Nuvation Bio (NUVB) Is Up 23.3% After First Patient Enrolled in Phase 3 TRUST-IV Trial - Sahm
Nuvation Bio Inc Azioni (NUVB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.67%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):